IL27 and diabetes mellitus: In contrast, anti-IL-27 antibody-treated diabetic splenocytes were transferred into NOD-SCID mice, showing increased incidence of diabetes, elevated blood glucose and IFNγ and IL-17 expression, and reduced expression of IL-4, TGF-β, and IL-10 (217).